Atlas Trials

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Clinical trial NCT02216357 · COMPLETED

Trial details

NCT number
NCT02216357
Sponsor
Cumberland Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aspirin Exacerbated Respiratory Disease (AERD)
Start date
2014-08-01
Primary completion
2016-01-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.